Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Relistor

- PMLiVE

Valeant offers $45.7bn for Botox firm Allergan

Trend for major pharma deals continues

- PMLiVE

Pfizer rumoured to be after AstraZeneca

Is this the return of the pharma mega-merger?

Pharma deals during March 2014

Deal Watch: Major pharma collaborations, acquisitions and agreements in the past month

- PMLiVE

Publicis boosts South Africa presence

Agency acquires local creative agency OwenKessel

Deal Watch table for March 2014

Table listing all the major pharma mergers, acquisitions and collaborations in the past month

- PMLiVE

US jury says Takeda and Lilly must pay $9bn in Actos damages

Court says companies covered up cancer risks of diabetes drug

- PMLiVE

Mallinckrodt cuts $5.6bn deal to buy Questcor

Irish company continues move from medical imaging to pharma products

- PMLiVE

Sun Pharma offers $4bn for Ranbaxy

Follows period of manufacturing problems at Daiichi-owned Indian generics company

- PMLiVE

EU approval for Takeda’s schizophrenia drug

Latuda said to have improved side effect profile compared to other treatments

Otsuka’s Samsca heads clutch of Japanese approvals

Astellas' Xtandi, AstraZeneca's Forxiga and Takeda's Zacras also given the green light

- PMLiVE

Takeda promotes Giles Platford

Appoints him head of commercial operations, emerging markets

Pharma deals during February 2014

Deal Watch: Major pharma collaborations, acquisitions and agreements in the past month

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links